BeyondSpring
Biopharma, Biotechnology, Health Care · 35 employees
BeyondSpring Inc. is a biopharmaceutical company focused on developing innovative cancer therapies. The company aims to improve patient outcomes through the development of novel therapeutics. Based in Florham Park, New Jersey, BeyondSpring prioritizes research and clinical trials in oncology. They are committed to addressing unmet medical needs in cancer treatment.
Funding history
- Series registered offering — $2.0M — Nov 2025
- Funding Round — $7.2M — Mar 2017
Recent signals
- Jun 04, 2026: BeyondSpring Appoints Min Qiu as Chief Executive Officer and Na Li as Chief Financial Officer
- Nov 21, 2025: Raised $2.0M in Series registered offering
- Nov 17, 2025: SEC 8-K (1.01): On November 17, 2025, BeyondSpring Inc. entered into a Securities Purchase Agreement with Ray Beauty Group Limited to issue and sell 800,000 shares of its ordinary shares at a purchase price of $2.50 per share. The transaction closed on November 21, 2025, generating gross proceeds of $2.0 million before expenses. This agreement expands BeyondSpring's capital resources and reflects strategic collaboration with the investor, aimed at funding future growth initiatives.
- Mar 21, 2017: Raised $7.2M
See plans & pricing → Track BeyondSpring’s funding, hiring, and signals — with verified contacts — on Fundz.